Form 4: Instil Bio CFO Sandeep Laumas Acquires 44,851 Shares Through Employee Stock Option

Sandeep Laumas, CFO and CBO of Instil Bio, Inc., acquired 44,851 shares of common stock through an employee stock option on April 25, 2025.

Summary

• On April 25, 2025, Sandeep Laumas, the CFO and CBO of Instil Bio, Inc., exercised an employee stock option.
• This transaction resulted in the acquisition of 44,851 shares of Instil Bio's common stock.
• The exercise price of the option was $12.78 per share.
• Following the transaction, Laumas directly owns 44,851 derivative securities.
• The options vest over time, with 25% vesting on April 25, 2026, and the remainder vesting in 36 equal monthly installments thereafter, contingent upon continued service.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard insider transaction. The acquisition of shares by an executive is generally viewed as a positive sign, but it's a routine part of executive compensation.

Positives

• The acquisition of shares by a high-ranking officer may signal confidence in the company's future prospects.

Future Outlook

The vesting schedule indicates a long-term commitment from the CFO, as continued service is required for full vesting of the options.

Industry Context

Form 4 filings are routine disclosures for corporate insiders and provide transparency into their transactions in company stock.

Key Dates

Keywords

Instil Bio, Sandeep Laumas, Form 4, Employee Stock Option, CFO, CBO, Beneficial Ownership, Securities